SavedAdd your journal

Journals / Endokrinolojide Yönelişler / 2004 / Cilt: 13 - Sayı: 4

von Willebrand factor levels in patients with hypothyroidism

Hipotiroidili hastalarda von Willebrand faktör düzeyleri

Ayşegül UĞUR
Ahmet KAYA
Erdal KURTOĞLU
Pages
123–124
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presence of AvWS should be considered in all patients with hypothyroidism before biopsy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acquired von Willebrand syndome (AvWS) is a.disease which occurs in ones with previosuly normal hemostasis.
📊
Key Findings & Data:We measured the von Willebrand factor levels of 18 patients with hypothyroidism and compared to that of healthy ones.
💡
Conclusion & Impact:Presence of AvWS should be considered in all patients with hypothyroidism before biopsy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acquired von Willebrand syndome (AvWS) is a.disease which occurs in ones with previosuly normal hemostasis. Hypothroidism is mentioned as an important cause n the etiology. We measured the von Willebrand factor levels of 18 patients with hypothyroidism and compared to that of healthy ones. We found that von Willebrand levels were significantly low in patients with hypothyro¬idism (p < 0.05). Presence of AvWS should be considered in all patients with hypothyroidism before biopsy.

Özet

Edinsel von-Willebrand sendromu (EvWS) daha önce hemostatik açıdan tümüyle normal olan kişilerde ortaya çıkan bir hastalıktır. Etyolojide önemli olan hastalıklardan birisi olarak hipotiroidi belirtilmektedir. Biz çalışmamızda hipotroidi tanısı almış 18 hastada von Willebrand faktör düzeyini inceleyerek sağlıklı kişilerle karşılaştırdık. Hipo-tiroidili hastalarda von Willebrand düzeyinin anlamlı olarak daha düşük olduğunu tespit ettik (p < 0.05). Hi¬potiroidi tanısı konulmuş bütün olgularda EvWS'u olabileceği bu hastalara biyopsi uygulamaları öncesinde mutlaka düşünülmelidir.

🔖

Cite This Article

UĞUR, A., KAYA, A., KURTOĞLU, E. (2022). von Willebrand factor levels in patients with hypothyroidism. Endokrinolojide Yönelişler, Cilt: 13 - Sayı: 4, 123–124. https://ajindex.com/articles/500852

References (9)

  1. Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome-report of JO case s and review of die literature. Haemophilia J 999; 5: 318-26. 2. de Lange DW, Fijnheer R, Wittebol S. Acquired von Willebrand syndrome. Ned Tijdschr Geneeskd 2003; 147: 1808-11
  2. Hennessy BJ, While 11, Byrne M, Smith OP. Acquired von Willebrand's disease. Ir J Med Sci 1998; 167:81-5
  3. Kinder MR, Richard RE, Rinder KM. Acquired von Willebrand's diseases concise review. Am J Hematol 199/, 54; 139-45
  4. Michiels JJ, Bedde U, von der Planken M, van Vliet fill, Schroyens W, Berneman Z. Besi I1 met Res Clin Haematol 2001; 14; 401-36
  5. Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl thromb Hemost 2001; 7: U3-5
  6. Chadarevian R, Brucken E, Leenhardt L, Giral P, Ankri A,Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001; 86; 732-7
  7. Myrup B, Bregengard C, Faber J. Primary haemostasis in thyroid disease, J Intern Med. 1995; 238(1): 59-63
  8. Baumgartner-Parzer SM, Wagner L, Reining G, Sexl V, Nowotny P, Muller M et al. Increase by tri-iodothyroninc of endothelin-l, libronectin and von Willebrand factor in cultured cells. J Endocrinol 1997; 154(2): 231-9, 10. Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbel GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. EurJ Clin Invest 2001: 3U2): 131-7
  9. Nagasaki T, lnaba M, Henmi Y, Kumeda Y,Ueda M, Taliara H et al. Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyro- xine replacement therapy. Eur J Endocrinol 2004; 150(2): 125-31.